Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-361-9 | CAS number: -
Toxicological information
Acute Toxicity: oral
Currently viewing:
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized
- EC Number:
- 295-344-3
- EC Name:
- Fatty acids, C10-20 and C16-18-unsatd., reaction products with triethanolamine, di-Me sulfate-quaternized
- Cas Number:
- 91995-81-2
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Stepantex VS 90
- Physical state: pale yellow paste, supplied by Stepan Europe
- Analytical purity: dry content 89.6 %
- Purity test date: 1991-04-29
- Lot/batch No.: LOT 111257
- Storage condition of test material: room temperature
- Other: Specific gravity (SG ) 0.95
- pH: 3 at a 5 % solution in IPA
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa Credo, 69210 L'Arbresle, France
- Age at study initiation: 6 weeks
- Weight at study initiation: males: 185 +/- 6 g; females: 151 +/- 7 g
- Fasting period before study: approx. 18 hours before administration of the test substance
- Housing: in groups of 5 animals of the same sex during the study, in polycarbonate cages (48 x 27 x 20 cm)
- Diet: ad libitum, Rats - Mice sustenance fef. A04 C (U.A.R. 91360 Villemoisson-sur.Orge, France)
- Water: ad libitum, tap water filtered by a 0.22 micron filter membrane
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 °C
- Humidity (%): 50 +/- 20 %
- Air changes (per hr): conventional air- conditioned animal room
- Photoperiod (hrs dark / hrs light): 12 hours of light / 12 hours of dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The administrations were performed in a single dose by oral route using a stainless steel round-shaped probe fitted to a 1 mL glass syringe.
The specific gravity of the test substance of 0.95 was taken into account. - Doses:
- 2000 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- other: historical laboratory data
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical signes: after administration and at least once a day thereafter; mortality: twice daily; body weight:
just before administration and then on day 5, 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, after opening the thoracic and abdominal cavities,
After opening the thoracic and abdominal cavities, a macroscopic examination of the main organs was performed:
digestive tract, heart, kidneys, liver, lungs, pancreas, spleen and any other organ with obvious abnormalities.
In the presence of macroscopic lesions, organ samples will be taken and histological examination will be performed.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Remarks on result:
- other: nominal
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 4 480 mg/kg bw
- Remarks on result:
- other: based on a.i.
- Mortality:
- No deaths occurred at the dose levels of 2000 and 5000 mg/kg during the observation period.
- Clinical signs:
- No clinical signs were observed in the animals treated at the dose level of 2000 mg/kg bw.
Hypokinesia was noted only in the treated males at the dose level of 5000 mg/kg bw, 30 minutes and one hour after treatment, then in all the animals
after 2 and 4 hours. From day 2 to day 15, no clinical signs were observed. - Body weight:
- The body weight gain of the animals was normal at 2000 mg/kg and of the females at 5000 mg/kg. A slight slowed down of the body weight gain was
noted between day 1 and day 5 in the males at 5000 mg/kg. - Gross pathology:
- Due to the absence of macroscopic lesions, no organ samples were taken and no histological examination was performed.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
